Chemours (CC) Misses Q4 EPS by 1c ; Provides Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Chemours (CC) PT Lowered to $20 at Jefferies
February 19, 2025 5:43 AM ESTJefferies analyst Laurence Alexander lowered the price target on Chemours (NYSE: CC) to $20.00 (from $21.00) while maintaining a Hold rating.
The analyst comments "Q4 EBITDA of $179 was $14m above both consensus and our estimate. 2025 EBITDA is pegged at $825-$975m (consensus... More
